未登录

V

Vicki Osborne

University of Portsmouth

H指数:12

被引数:576

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prescription Opioid Use Among a Community Sample of Older and Younger Women

JOURNAL OF WOMENS HEALTH

IF1.9

2022-02-010

OA

Opioids in the United Kingdom: safety and surveillance during COVID-19

英国的阿片类药物: 新型冠状病毒肺炎期间的安全和监测

CURRENT OPINION IN PSYCHIATRY

IF4.9

2021-05-143

OA

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology

IF3.8

2021-05-071

OAAI

Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?

BMJ EVIDENCE-BASED MEDICINE

IF7.6

2020-10-2121

OAAI

Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY

IF4

2020-09-021

OAAI

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment

IF3.8

2020-06-2343

OAAI

Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment

IF3.8

2020-05-2845

OAAI

Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management

BMJ EVIDENCE-BASED MEDICINE

IF7.6

2020-02-247

OAAI

Sex differences in patterns of prescription opioid non-medical use among 10-18 year olds in the US

ADDICTIVE BEHAVIORS

IF3.6

2019-02-0121

PREAI

Power of the Peer and Parent: Gender Differences, Norms, and Nonmedical Prescription Opioid Use Among Adolescents in South Central Kentucky

PREVENTION SCIENCE

IF2.7

2019-01-1423

OAAI

First Conference on Big Data for Pharmacovigilance

IF3.8

2018-09-192

PREAI

Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System

IF3.8

2017-11-0229

PREAI

Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England

IF3.8

2017-10-108

PREAI

Non-medical opioid use in youth: Gender differences in risk factors and prevalence

ADDICTIVE BEHAVIORS

IF3.6

2017-09-0161

OAAI

The 9th Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance

IF3.8

2017-08-091

PREAI

POTENTIAL IMPACT OF EXPOSURE DEFINITION WHEN EXAMINING NON-MEDICAL USE OF PRESCRIPTION OPIOIDS AMONG US VETERANS

IF5.3

2017-06-121

OAAI

Risk factors for prescription opioid misuse by duration of misuse

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2017-02-010

PREAI

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England

IF3.8

2016-01-2115

OAAI

Indicators of Drug-Seeking Aberrant Behaviours: The Feasibility of Use in Observational Post-Marketing Cohort Studies for Risk Management

IF3.8

2014-06-278

OAAI

Examining the Utilization and Tolerability of the Non-Sedating Antihistamine Levocetirizine in England Using Prescription-Event Monitoring Data

IF3.8

2011-12-016

PREAI